U.N. progress report on AIDS stresses advances in treatment, prevention, warns about declining funding

"Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term," according to a new report from the WHO, UNICEF and UNAIDS, which also "indicates that increased access to HIV services resulted in a 15 percent reduction of new infections over the past decade and a 22 percent decline in AIDS-related deaths in the last five years," a WHO press release reports (11/30). The report, titled "Progress report 2011: Global HIV/AIDS response," notes that "[a]s capacity at all levels increases, programs are becoming more effective and efficient," but "financial pressures on both domestic and foreign assistance budgets are threatening the impressive progress to date. Recent data indicating that HIV funding is declining is a deeply troubling trend that must be reversed for the international community to meet its commitments on HIV" (11/30).

"With many large international donor countries struggling with recession and debt crises, [Director of the WHO HIV Department Gottfried] Hirnschall said it was crucial for countries affected by HIV/AIDS to do all they can to fund their own programs and make limited resources go further," Reuters writes, adding, "Hirnschall said donors should recognize that stepping up investment now will save lives, and more money in the long run" (Kelland, 11/30).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
World Lung Day 2024: Bedfont® Scientific Limited. Leads the Way in Asthma Care with the NObreath® FeNO Device